Navigation Links
NCPA Commends Senate Aging Committee for Launching CVS Caremark Investigation to Examine Alleged Harm to Seniors, Medicare

ALEXANDRIA, Va., Sept. 29 /PRNewswire-USNewswire/ -- The National Community Pharmacists Association (NCPA) expressed strong support for an investigation into CVS Caremark launched by the U.S. Senate Special Committee on Aging reported earlier today on the blog Pharmalot.



In response, NCPA President Joseph H. Harmison, PD and Arlington, Texas pharmacy owner, issued the following statement:

"Complaints continue to increase from patients and community pharmacists alleging CVS Caremark of engaging in anti-consumer, anti-competitive behavior. We commend Chairman Herb Kohl (D-Wisc.) for doing the right thing on behalf of patients and pharmacists in Wisconsin and across the nation.  Seniors are both the most in need of pharmacy services and the patients arguably most vulnerable to the misleading and deceptive tactics of which CVS Caremark is accused.

"CVS Caremark's strong-armed efforts to gain market share appear to be compromising patient care while inflating costs for seniors, the Medicare program and taxpayers. For example, retirees Max and Jan Hauser discovered that, under their Medicare drug plan administered by CVS Caremark, the cholesterol drug Simvastatin that cost them nothing at a local independent pharmacy cost them $165.99 at CVS for a three-month supply. As reported by WCNC-TV they were also charged more by CVS for ulcer drugs and blood pressure medicine. The combined higher costs charged by CVS pushed the fixed-income couple into their plan's coverage gap (or 'donut hole') sooner, significantly increasing their out-of-pocket drug costs.

"In addition, seniors who prefer the face to face service and counseling of their independent community pharmacist are forced by CVS Caremark to switch to its mail order or to travel greater distances to the nearest CVS location. In the newly released J.D. Power and Associates 2010 National Pharmacy Study, patients rated CVS Caremark retail and mail order pharmacies significantly lower than its rivals in customer satisfaction.

"The Senate committee joins a long and growing list of investigations into anti-consumer, anti-competitive allegations against CVS Caremark. The Federal Trade Commission is in the midst of a non-public investigation involving both its Bureaus of Competition and Consumer Protection and with the support of dozens of members of Congress. In addition, approximately 24 states are pursuing their own investigations. Community pharmacists and their patients are looking for comprehensive relief from the FTC and other regulators to stop any anti-competitive and deceptive practices by CVS Caremark."

The National Community Pharmacists Association (NCPA®) represents America's community pharmacists, including the owners of more than 22,700 independent community pharmacies, pharmacy franchises, and chains. Together they represent an $88 billion health-care marketplace, employ over 65,000 pharmacists, and dispense over 40% of all retail prescriptions. To learn more go to or read NCPA's blog, The Dose, at

SOURCE National Community Pharmacists Association
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Test for Life Commends North Carolina Rules Commission for Implementing CDC Recommendations for HIV Testing
2. CHMP Recommends Expanded Use of Angiox(R) (Bivalirudin) in Europe for Patients With Acute Coronary Syndromes
3. Independent Data Safety Monitoring Board Recommends Continuation of Sangarts Pivotal Phase III Trials of Hemospan(R) Following Second Interim Review
4. FDA Advisory Committee Unanimously Recommends U.S. Approval of Sugammadex, the First and Only Selective Relaxant Binding Agent
5. Lung Cancer Alliance Commends NCCN on Screening Guidelines
6. FDA Advisory Committee Unanimously Recommends Approval of Ustekinumab for Treatment of Moderate to Severe Plaque Psoriasis
7. Task Force Recommends Screening for Hearing Loss in All Newborns
8. CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients
9. Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout
10. CHMP Recommends Approval in the European Union (EU) for New Options for Patients With Certain Primary Brain Tumors
11. Independent Data Monitoring Committee Recommends Resuming Enrollment of Non-Squamous NSCLC Patients in the Motesanib MONET1 Trial
Post Your Comments:
(Date:11/30/2015)... December 1, 2015 ... adds "Endometriosis - Pipeline Review, H2 2015" ... on therapeutic pipeline of Endometriosis and helps ... counter strategies to gain competitive advantage. It ... and MOAs to produce first-in-class and best-in-class ...
(Date:11/30/2015)... 2015  DURECT Corporation (Nasdaq: DRRX ... , Chief Financial Officer, will be presenting ... December 8 at 2:45 pm Eastern Time.  ... Westin Grand Central Hotel in New York.  ... meetings at this conference; interested institutional investors ...
(Date:11/30/2015)...   Royal Philips  (NYSE: PHG ; ... Solutions, a fully integrated, consultative approach to enhance ... practice management approaches that combine imaging systems, services, ... care delivery and reduce costs. Making its debut ... America Annual Meeting (RSNA) in ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... December 01, 2015 , ... The Turks & Caicos Islands has ... leading digital news sites highlighting Caribbean destinations, has published five reasons to visit the ... North America shivers under chilly grey skies or worse, it's typically a balmy 80 ...
(Date:11/30/2015)... ... December 01, 2015 , ... ... Jones as a 2015-2016 inductee into its VIP Woman of the Year ... is the nation’s leading networking organization exclusively for professional women, boasting 850,000 members ...
(Date:11/30/2015)... BALTIMORE, Md. (PRWEB) , ... November 30, 2015 ... ... be rewarding, but also extremely stressful. At the VA Maryland Health Care ... who care for veterans patients. “Caregivers have a difficult job. Seventy-four percent ...
(Date:11/30/2015)... ... 2015 , ... Stress, anxiety, illness, infection or even a need for eyeglasses ... Heather Spader, MD, a new pediatric neurosurgeon at Joe DiMaggio Children’s Hospital in Hollywood, ... tumors. , “Bad headaches that don’t go away, that don’t have any ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... The directory is specialized and only includes chiropractic clinics in the US. , ... and trustworthy alternative health practitioner when back pain sets in. When people are ...
Breaking Medicine News(10 mins):